Trial intelligence / Profile preview

HEROES-12: H. pylori Eradication in Functional Dyspepsia

NCT00404534Phase 3Completed

Sponsor
Hospital de Clínicas de Porto Alegre
Start
Oct 2006
Primary completion
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of amoxicillin, clarithromycin in functional dyspepsia (FD), Helicobacter pylori infection, sponsored by Hospital de Clínicas de Porto Alegre. Started Oct 2006; status: completed.

02

Drugs

amoxicillinclarithromycin
03

Conditions

functional dyspepsia (FD)Helicobacter pylori infection

Beyond the preview

Go deeper on NCT00404534.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00404534.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call